Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, CB#3270, Chapel Hill, NC, 27599-3270, USA.
Psychopharmacology (Berl). 2020 Dec;237(12):3653-3664. doi: 10.1007/s00213-020-05645-2. Epub 2020 Aug 28.
Converging evidence suggests opioid abuse can increase the incidence and severity of post-traumatic stress disorder (PTSD) in clinical populations. Interestingly, opioid withdrawal alone can produce symptoms similar to those of PTSD. Despite this association, the neural mechanisms underlying the relationship of opioid abuse, withdrawal, and PTSD is poorly understood. Our laboratory has investigated the neurobiological underpinnings of stress-enhanced fear learning (SEFL), an animal model of PTSD-like symptoms. We have previously shown that, in SEFL, a severe footshock induces an increase in dorsal hippocampal (DH) interleukin-1β (IL-1β), and subsequent fear learning is blocked by DH IL-1 receptor antagonism (IL-1RA). Given that opioids and stress engage similar neuroimmune mechanisms, the present experiments investigate whether the same mechanisms drive heroin withdrawal to induce a PTSD-like phenotype. First, we tested the effect of a chronic escalating heroin dose and withdrawal regimen on fear learning and found it produces enhanced future fear learning. Heroin withdrawal also induces a time-dependent, region-specific increase in IL-1β and glial fibrillary acidic protein (GFAP) immunoreactivity within the dentate gyrus of the DH. IL-1β was significantly colocalized with GFAP, indicating astrocytes may be involved in increased IL-1β. Moreover, intra-DH infusions of IL-1RA 0, 24, and 48 h into heroin withdrawal prevents the development of enhanced fear learning but does not alter withdrawal-induced weight loss. Collectively, our data suggests heroin withdrawal is sufficient to produce enhanced fear learning, astrocytes may play a role in heroin withdrawal-induced IL-1β, and DH IL-1 signaling during withdrawal mediates the development of heroin withdrawal-enhanced fear learning.
越来越多的证据表明,阿片类药物滥用会增加临床人群中创伤后应激障碍(PTSD)的发生率和严重程度。有趣的是,阿片类药物戒断本身就会产生类似 PTSD 的症状。尽管存在这种关联,但阿片类药物滥用、戒断和 PTSD 之间关系的神经机制仍知之甚少。我们的实验室研究了应激增强的恐惧学习(SEFL)的神经生物学基础,这是 PTSD 样症状的动物模型。我们之前已经表明,在 SEFL 中,剧烈的足底电击会导致背侧海马(DH)白细胞介素-1β(IL-1β)增加,随后的恐惧学习会被 DH IL-1 受体拮抗剂(IL-1RA)阻断。鉴于阿片类药物和应激会引发相似的神经免疫机制,本实验研究了是否相同的机制会导致海洛因戒断引发 PTSD 样表型。首先,我们测试了慢性递增海洛因剂量和戒断方案对恐惧学习的影响,发现它会导致未来恐惧学习增强。海洛因戒断还会导致 DH 齿状回中 IL-1β 和胶质纤维酸性蛋白(GFAP)免疫反应出现时间依赖性、区域特异性增加。IL-1β 与 GFAP 显著共定位,表明星形胶质细胞可能参与了 IL-1β 的增加。此外,在海洛因戒断后 0、24 和 48 小时,DH 内注射 IL-1RA 可防止增强的恐惧学习的发展,但不会改变戒断引起的体重减轻。总的来说,我们的数据表明海洛因戒断足以产生增强的恐惧学习,星形胶质细胞可能在海洛因戒断诱导的 IL-1β中发挥作用,而戒断期间 DH IL-1 信号传导介导了海洛因戒断增强的恐惧学习的发展。